Gitnux/Report 2026

Longevity Statistics

Healthcare is a staggering $3.6% of global GDP in low income countries versus 15.3% in the United States and 14.8% in France, yet the funding for the longevity pipeline is smaller than most people expect with just 8.0% of health spending going to health R and D in 2021. See how the mix of long term care costs, survival gains, and emerging tech markets like AI in healthcare and digital therapeutics helps explain both the opportunity and the bottlenecks for living longer with better health.
59Statistics
59Sources
5Sections
7mRead
May 14, 2026Updated
Longevity Statistics
How this report is researched
01Editorial Scope

Before any source is gathered, an editor locks the question, what qualifies, and how the piece will be judged.

02Source Research

Search agents collect the source set and pull each data point out with its provenance attached.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days
Longevity is being reshaped by spending and outcomes, but the split is surprisingly uneven. Global health R&D took 8.0% of health spending in 2021, while total healthcare consumption is far broader, with the US at 6.3% of GDP in 2022 and low-income countries at just 3.6% of global GDP in healthcare in the same period. As the care burden grows with 1.5 billion people aged 65+ projected by 2050, these funding and survival metrics start to reveal where progress is accelerating and where it still lags.

Key Takeaways

  • 8.0% global health spending share spent on health R&D in 2021
  • $2.7 trillion global long-term care spending in 2019 (latest global estimate widely cited by OECD)
  • 6.3% of GDP spent on healthcare in the United States in 2022
  • 1.5 billion people aged 65+ worldwide in 2050 projected by UN
  • 11.3% share of global population aged 65+ in 2019
  • US life expectancy at birth was 77.5 years in 2022 (CDC)
  • In-hospital mortality for heart failure was 4.3% in 2022 (AHA/NCDB)
  • Cancer 5-year relative survival rate was 67% (US, 2015-2019, NCI SEER)
  • Breast cancer 5-year relative survival was 91% (US, 2015-2019, NCI SEER)
  • Australia life expectancy at birth was 84.3 years in 2022 (World Bank)
  • UK life expectancy at birth was 81.3 years in 2022 (World Bank)
  • In the US, 73% of adults have used health information online (Pew Research Center, 2019)
  • US FDA approved 77 drug approvals in 2022 (CDER annual report)
  • US FDA approved 55 new molecular entities/BLAs in 2021 (FDA CDER)
  • Per-capita healthcare spending in Switzerland was $10,381 (current US$) in 2022 (World Bank)

Spending and longevity tech are rising fast, while heart disease, cancer, and dementia still drive major deaths.

01 · Category

Market Size21 stats

01
8.0% global health spending share spent on health R&D in 2021https://apps.who.int/gho/data/node.main.1224
02
$2.7 trillion global long-term care spending in 2019 (latest global estimate widely cited by OECD)https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019-long-term-care_5d7f0b7d-en
03
6.3% of GDP spent on healthcare in the United States in 2022https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=US
04
15.3% of GDP spent on healthcare in Germany in 2022https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=DE
05
14.8% of GDP spent on healthcare in France in 2022https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=FR
06
3.6% of total global GDP spent on healthcare in low-income countries in 2022https://data.worldbank.org/indicator/SH.XPD.CHEX.GD.ZS?locations=ZG
07
$7,954per capita current health expenditure in the United States in 2021https://data.worldbank.org/indicator/SH.XPD.CHEX.PP.CD?locations=US
08
$4,324per capita current health expenditure (PPP) in Germany in 2021https://data.worldbank.org/indicator/SH.XPD.CHEX.PP.CD?locations=DE
09
$3,944per capita current health expenditure (PPP) in France in 2021https://data.worldbank.org/indicator/SH.XPD.CHEX.PP.CD?locations=FR
11
$90.0 billion global market size for remote patient monitoring in 2023 (forecast)https://www.grandviewresearch.com/industry-analysis/remote-patient-monitoring-market
13
$13.6 billion global market size for assisted living services in 2022 (forecast)https://www.alliedmarketresearch.com/assisted-living-market-A11464
14
$4.1 billion global market size for home healthcare services in 2022 (forecast)https://www.precedenceresearch.com/home-healthcare-services-market
15
$15.0 billion global market size for wearable devices in healthcare in 2023 (forecast)https://www.idc.com/getdoc.jsp?containerId=US51252523
16
$21.7 billion global market size for longevity market services in 2023 (market estimate)https://www.fortunebusinessinsights.com/longevity-market-106816
17
$19.4 billion global market size for the geriatric care market in 2021 (forecast)https://www.marketsandmarkets.com/Market-Reports/geriatric-care-market-131471056.html
18
$54.5 billion global market size for anti-aging products in 2023https://www.marketsandmarkets.com/Market-Reports/anti-aging-products-market-1104.html
19
$2.7 billion global market size for telerehabilitation in 2023 (forecast)https://www.researchandmarkets.com/reports/5949175/telerehabilitation-market-global-opportunities-and
20
$2.9 billion global market size for AI in healthcare in 2020; $99.6 billion forecast by 2030https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-ai-in-healthcare-market
21
$55.2 billion global market size for digital therapeutics in 2022; $251.7 billion forecast by 2032https://www.grandviewresearch.com/industry-analysis/digital-therapeutics-market
Interpretation

Market Size Interpretation

The market size data shows rapid expansion across health and longevity services, with global spending rising from $90.0 billion for remote patient monitoring in 2023 to $21.7 billion for longevity market services in 2023 and even larger long-term growth forecasts like AI in healthcare expanding from $2.9 billion in 2020 to $99.6 billion by 2030.

03 · Category

Performance Metrics12 stats

02
Cancer 5-year relative survival rate was 67% (US, 2015-2019, NCI SEER)https://seer.cancer.gov/statfacts/html/common.html
03
Breast cancer 5-year relative survival was 91% (US, 2015-2019, NCI SEER)https://seer.cancer.gov/statfacts/html/breast.html
04
In the US, 1-year survival for localized prostate cancer exceeded 99% (SEER)https://seer.cancer.gov/statfacts/html/prost.html
05
Strokes mortality in the US was 133.5 deaths per 100,000 population in 2022 (CDC)https://www.cdc.gov/nchs/fastats/stroke.htm
06
Ischemic heart disease death rate was 113.9 per 100,000 population in 2022 (CDC)https://www.cdc.gov/nchs/fastats/heart-disease.htm
07
Blood pressure control (treated and at goal) among US adults was 52% in 2017-2018 (CDC/NCHS)https://www.cdc.gov/nchs/products/databriefs/db375.htm
08
Average waiting time for elective treatment in England was 7.9 weeks in 2023-24 (NHS England)https://www.england.nhs.uk/statistics/statistical-work-areas/referral-to-treatment-waiting-times/
09
UK delayed transfers of care averaged 22,000 patients in March 2024 (NHS England)https://www.england.nhs.uk/statistics/statistical-work-areas/delayed-transfers-of-care/
10
Median age at death in the US was 77.0 years in 2022 (NCHS)https://www.cdc.gov/nchs/products/databriefs/db480.htm
11
Life expectancy gains: global life expectancy at birth increased from 66.8 years in 2000 to 73.0 years in 2019 (UN/World)https://ourworldindata.org/life-expectancy
12
Global premature mortality from non-communicable diseases accounted for 37% of NCD deaths under age 70 (WHO GHO)https://www.who.int/data/gho/data/themes/noncommunicable-diseases
Interpretation

Performance Metrics Interpretation

Across major performance metrics for health outcomes, survival and care quality show strong variation, with breast cancer 5-year relative survival at 91% and localized prostate cancer 1-year survival above 99% contrasting sharply with higher population-level burdens like ischemic heart disease at 113.9 deaths per 100,000 and strokes at 133.5 deaths per 100,000 in 2022.

04 · Category

User Adoption11 stats

01
Australia life expectancy at birth was 84.3 years in 2022 (World Bank)https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=AU
02
UK life expectancy at birth was 81.3 years in 2022 (World Bank)https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=GB
03
In the US, 73% of adults have used health information online (Pew Research Center, 2019)https://www.pewresearch.org/internet/2019/04/22/health-online/
04
In the US, 38% of adults track health or fitness data using devices/apps (Pew Research Center, 2023)https://www.pewresearch.org/internet/2023/08/15/people-are-using-ai-tools-but-their-impact-is-not-yet-clear/
05
In the US, 49% of adults say they have a wearable device used for fitness/health (Pew Research Center, 2023)https://www.pewresearch.org/science/2022/05/10/usb-and-mobile-phone-access/
06
In Germany, 41% of people used online medical information in 2022 (Eurobarometer)https://europa.eu/eurobarometer/surveys/detail/2240
07
In the EU, 46% of people used the internet to find medical information in 2022 (Eurobarometer)https://europa.eu/eurobarometer/surveys/detail/2722
08
In the UK, 14.9% of people used digital health tools in the last 12 months (NHS)https://www.nhs.uk/nhs-services/online-services/
09
In the US, 60% of adults report taking dietary supplements in 2017-2018 (NIH NHANES)https://ods.od.nih.gov/factsheets/Dietary_Supplements-Consumer_Usage_and_Impact/
11
BioTech funding for aging/longevity-focused startups reached $5.5B in 2021 (Dealroom)https://www.dealroom.co/report/longevity-2022
Interpretation

User Adoption Interpretation

User adoption is surging from information seeking to active self tracking, with 73% of US adults using health information online and 38% tracking fitness or health data with devices or apps, alongside strong momentum in wearable and testing markets like a $1.64 billion direct to consumer longevity testing forecast for 2023.

05 · Category

Cost Analysis5 stats

01
US FDA approved 77 drug approvals in 2022 (CDER annual report)https://www.fda.gov/media/165915/download
02
US FDA approved 55 new molecular entities/BLAs in 2021 (FDA CDER)https://www.fda.gov/media/150409/download
03
Per-capita healthcare spending in Switzerland was $10,381(current US$) in 2022 (World Bank)https://data.worldbank.org/indicator/SH.XPD.CHEX.PP.CD?locations=CH
04
Per-capita healthcare spending in India was $2,041(current US$ PPP) in 2022 (World Bank)https://data.worldbank.org/indicator/SH.XPD.CHEX.PP.CD?locations=IN
05
UK NHS cost of a hospital bed day averaged £485 in 2022-23 (NHS Reference Costs)https://improvement.nhs.uk/documents/CRS%20Reference%20Costs%202022-23%20template.pdf
Interpretation

Cost Analysis Interpretation

From a Cost Analysis perspective, the sharp disparity in per-capita healthcare spending from Switzerland at $10,381 in 2022 to India at $2,041 in PPP terms, alongside the UK NHS average bed day cost of £485, suggests that the same drug or treatment availability gains can translate into very different system-level costs depending on country spending levels.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Megan Gallagher. (2026, February 13). Longevity Statistics. Gitnux. https://gitnux.org/longevity-statistics
MLA
Megan Gallagher. "Longevity Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/longevity-statistics.
Chicago
Megan Gallagher. 2026. "Longevity Statistics." Gitnux. https://gitnux.org/longevity-statistics.